Enanta Pharmaceuticals
ENTA
#7604
Rank
ยฃ0.30 B
Marketcap
ยฃ10.60
Share price
3.31%
Change (1 day)
158.70%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -ยฃ57.95 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ65.32 Million. In 2024 the company made an earning of -ยฃ71.69 Million, an increase over its 2023 earnings that were of -ยฃ94.16 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ57.95 Million-19.16%
2024 -ยฃ71.69 Million-23.87%
2023 -ยฃ94.16 Million4.39%
2022 -ยฃ90.2 Million-4.4%
2021 -ยฃ94.36 Million91.12%
2020 -ยฃ49.37 Million-407.13%
2019 ยฃ16.07 M-78.63%
2018 ยฃ75.22 M117.97%
2017 ยฃ34.51 M-574.65%
2016 -ยฃ7.28 Million-110.83%
2015 ยฃ67.15 M-4.5%
2014 ยฃ70.32 M-638.53%
2013 -ยฃ13.06 Million-137.98%
2012 ยฃ34.37 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ24.79 B-44,324.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ12.08 B-21,653.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
ยฃ4.87 B-8,795.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ3.44 B-6,237.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ16.56 B-29,655.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ6.89 B-12,395.04%๐Ÿ‡บ๐Ÿ‡ธ USA